IT0005575078 20240902 18.2 News - I09881

Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report

Amsterdam, The Netherlands, and Holzgerlingen, Germany, July 01, 2020, 08:30 am CEST - Curetis N.V. in liquidatie (the "Company") today announced...

Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report

Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 30, 2020, 08:00 am CET - Curetis N.V. in liquidatie (the "Company") today announced...

Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day

Amsterdam, the Netherlands, Holzgerlingen, Germany April 20, 2020, 8:00 am CEST - Curetis N.V. in liquidatie (the "Company") announces that the...

Curetis and OpGen Close Business Combination

- Following approval of shareholders, companies sign German transfer agreement - Curetis GmbH and its subsidiaries Curetis USA Inc. and Ares...

OpGen Announces Shareholder Approval for Business Combination with Curetis

Vote approving transaction passes with 95% support for the transaction Closing expected in the coming days...

Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update

Quorum achieved for OpGen stockholder vote on Curetis business combination with 99% of votes supporting transactionTransaction close anticipated...

OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

Shareholder proxy vote achieves quorum with 99% support for the transaction Final step in OpGen / Curetis...

OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

GAITHERSBURG, Md., March 19, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision...

Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

, a developer of next-level molecular diagnostic solutions, today announced that it starts offering a CE-IVD certified real-time PCR test kit for...

Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020

Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, March 10, 2020, 16:15 pm CET - Curetis N.V. (the "Company" and...

Curetis N.V. Reports Results of the Extraordinary General Meeting Held on March 10, 2020

- Shareholders adopt all proposed resolutions - EGM votes clear way for closing of business combination with...

Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update

Revenue increases by 64% to EUR 2.3 million, up from 1.4 million in 2018More than tripled...

Curetis and Quaphaco Enter into Unyvero Distribution Partnership for Vietnam

Exclusive distribution agreement for initial term of 3 yearsQuaphaco commits to minimum purchase totaling about EUR 1.9 million during initial...

Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (...

BGI Group responds to coronavirus crisis by providing reagent kits for molecular 2019-nCoV testing by next-generation sequencing and RT-PCRAres...

Curetis to Hold Extraordinary General Meeting on March 10, 2020

Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, January 27, 2020, 08:00 am CET / 02:00 am EDT - Curetis N.V. (the...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

IT0005575078 20240902 18.2 (I09881)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

I09881 News

Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report

Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report

Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day

Curetis and OpGen Close Business Combination

OpGen Announces Shareholder Approval for Business Combination with Curetis

Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update

OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020

Curetis N.V. Reports Results of the Extraordinary General Meeting Held on March 10, 2020

Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update

Curetis and Quaphaco Enter into Unyvero Distribution Partnership for Vietnam

Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (...

Curetis to Hold Extraordinary General Meeting on March 10, 2020

I09881 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

IT0005575078 20240902 18.2 (I09881) News

IT0005575078 20240902 18.2 (I09881)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

I09881 News

Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report

Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report

Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day

Curetis and OpGen Close Business Combination

OpGen Announces Shareholder Approval for Business Combination with Curetis

Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update

OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020

Curetis N.V. Reports Results of the Extraordinary General Meeting Held on March 10, 2020

Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update

Curetis and Quaphaco Enter into Unyvero Distribution Partnership for Vietnam

Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (...

Curetis to Hold Extraordinary General Meeting on March 10, 2020

I09881 Discussion

Your Recent History